Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald A Smith

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|November 20, 2018
Review: In adults, increasing ω-6 fatty acid intake does not reduce mortality or overall cardiovascular eventsDonald A Smith
ACP Journal Club|September 5, 2003
Estrogen plus progestin reduced the incidence of diabetes in postmenopausal women with coronary heart diseaseDonald A Smith
ACP Journal Club|February 7, 2002
Cardiovascular events were increased in high cardiovascular risk patients with albuminuriaDonald A Smith
ACP Journal Club|May 3, 2005
Picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial diseaseDonald A Smith
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Review: statins are not associated with cognitive impairment, Alzheimer disease, or dementiaDonald A Smith
The Mount Sinai Journal of Medicine, New York|March 17, 2005
New trends in lipid management: eight cases to considerDonald A Smith
Annals of Internal Medicine|November 19, 2019
Review: In dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and strokeDonald A Smith
Annals of Internal Medicine|April 19, 2017
Review: Sulfonylureas are associated with overall mortality and CV events vs other antihyperglycemics in T2DMDonald A Smith
Annals of Internal Medicine|July 19, 2016
Incretin-based drugs were not linked to HF hospitalization compared with other oral antidiabetic drug combinationsDonald A Smith
ACP Journal Club|September 3, 2004
C-reactive protein was a moderate predictor of coronary heart diseaseDonald A Smith
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|November 20, 2018
Review: In adults, increasing ω-6 fatty acid intake does not reduce mortality or overall cardiovascular eventsDonald A Smith
ACP Journal Club|September 5, 2003
Estrogen plus progestin reduced the incidence of diabetes in postmenopausal women with coronary heart diseaseDonald A Smith
ACP Journal Club|February 7, 2002
Cardiovascular events were increased in high cardiovascular risk patients with albuminuriaDonald A Smith
ACP Journal Club|May 3, 2005
Picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial diseaseDonald A Smith
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Review: statins are not associated with cognitive impairment, Alzheimer disease, or dementiaDonald A Smith
The Mount Sinai Journal of Medicine, New York|March 17, 2005
New trends in lipid management: eight cases to considerDonald A Smith
Annals of Internal Medicine|November 19, 2019
Review: In dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and strokeDonald A Smith
Annals of Internal Medicine|April 19, 2017
Review: Sulfonylureas are associated with overall mortality and CV events vs other antihyperglycemics in T2DMDonald A Smith
Annals of Internal Medicine|July 19, 2016
Incretin-based drugs were not linked to HF hospitalization compared with other oral antidiabetic drug combinationsDonald A Smith
ACP Journal Club|September 3, 2004
C-reactive protein was a moderate predictor of coronary heart diseaseDonald A Smith
Pageof 6